Literature DB >> 12728040

Ten-year results with hydroxyapatite-coated total hip femoral components in patients less than fifty years old. A concise follow-up of a previous report.

William N Capello1, James A D'Antonio, Judy R Feinberg, Michael T Manley.   

Abstract

We report the results of total hip arthroplasty with use of a proximally hydroxyapatite-coated femoral component after a minimum follow-up of ten years in a group of patients who were less than fifty years old at the time of the primary procedure. In the five years since the original publication of our study, two additional stems have undergone revision. Thus, a total of six stems have been revised. A small amount of erosive scalloping of the proximal part of the femur was seen in nearly one-half of the hips; however, all unrevised stems were radiographically stable and no hip had intramedullary osteolysis. The revision rate because of aseptic loosening of the stem was 0.9%, which compares favorably with that for other stems and other fixation methods in young patients at this point in time. This stem is currently being paired with a highly cross-linked polyethylene liner because of cup failures and the need for reoperation secondary to excessive polyethylene wear and proximal femoral osteolysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12728040     DOI: 10.2106/00004623-200305000-00017

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  20 in total

Review 1.  [Results for endoprosthetic care in patients younger than 50 years].

Authors:  J Ziegler; M Amlang; M Bottesi; S Kirschner; W-C Witzleb; K-P Günther
Journal:  Orthopade       Date:  2007-04       Impact factor: 1.087

2.  Multi directional intertrochanteric osteotomy for primary and secondary osteoarthritis--results after 15 to 29 years.

Authors:  D Haverkamp; H Eijer; T W Patt; R K Marti
Journal:  Int Orthop       Date:  2005-12-22       Impact factor: 3.075

3.  Enhanced cell integration to titanium alloy by surface treatment with microarc oxidation: a pilot study.

Authors:  Young Wook Lim; Soon Yong Kwon; Doo Hoon Sun; Hyoun Ee Kim; Yong Sik Kim
Journal:  Clin Orthop Relat Res       Date:  2009-05-12       Impact factor: 4.176

4.  Why revision total hip arthroplasty fails.

Authors:  Bryan D Springer; Thomas K Fehring; William L Griffin; Susan M Odum; John L Masonis
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

5.  Durability of second-generation extensively porous-coated stems in patients age 50 and younger.

Authors:  Jennifer A Moyer; Catherine M Metz; John J Callaghan; David W Hennessy; Steve S Liu
Journal:  Clin Orthop Relat Res       Date:  2009-09-01       Impact factor: 4.176

6.  Cementless Total Hip Arthroplasty With Metasul Bearings Provides Good Results in Active Young Patients: A Concise Followup.

Authors:  Christian P Delaunay; Sophie Putman; Benjamin Puliéro; Matthieu Bégin; Henri Migaud; François Bonnomet
Journal:  Clin Orthop Relat Res       Date:  2016-10       Impact factor: 4.176

7.  Primary total hip arthroplasty with a proximally HA-coated titanium femoral component: results at 10-15-year follow-up.

Authors:  N A Sandiford; A Butler-Manuel; H D Apthorp; D J East; B L Hinves; J A N Shepperd
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-01-09

8.  An in vivo evaluation of bone response to three implant surfaces using a rabbit intramedullary rod model.

Authors:  Juan C Hermida; Arnie Bergula; Fred Dimaano; Monica Hawkins; Clifford W Colwell; Darryl D D'Lima
Journal:  J Orthop Surg Res       Date:  2010-08-16       Impact factor: 2.359

9.  Hip arthroplasty in patients younger than 30 years: excellent ten to 16-year follow-up results with a HA-coated stem.

Authors:  H Wangen; P Lereim; I Holm; R Gunderson; O Reikerås
Journal:  Int Orthop       Date:  2007-02-15       Impact factor: 3.075

10.  Custom stems for femoral deformity in patients less than 40 years of age: 70 hips followed for an average of 14 years.

Authors:  Michael Akbar; Guenther Aldinger; Knut Krahmer; Thomas Bruckner; Peter R Aldinger
Journal:  Acta Orthop       Date:  2009-08       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.